Answer
Severe renal impairment approximately halves total serum clearance of lanreotide acetate, increasing its half-life and AUC; however, GEP-NET patients with severely impaired renal function were not studied.
Sources for this answer
- Lanreotide ADVANZ PHARMA 120 mg solution for injection in a prefilled syringeADVANZ Pharma · emc · SmPC §5.2 Pharmacokinetic properties · Version 4Document updated
Sources checked